在帕金森病中切换和结合设备辅助疗法的长期影响和原因
Dejan Georgiev1,2,3, Maja Trost4,5
1Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia. dejan.georgiev@kclj.si.
Neurologia i neurochirurgia polska
|January 9, 2025
概括
设备辅助疗法 (DAT) 为晚期帕金森病 (PD) 提供长期益处. 当初始治疗不足或引起不良事件时,建议切换或组合DAT.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚期帕金森病 (PD) 通常需要设备辅助疗法 (DATs),当标准治疗失败时.
- DAT包括深度大脑刺激 (DBS),连续皮下阿波莫尔芬输液 (CSAI) 和莱沃多巴-卡比多巴肠凝 (LCIG) 输液.
- 由于不良事件或有效性丧失,患者可能需要切换或组合DAT.
研究的目的:
- 总结关于DAT在晚期PD的长期疗效和不良事件的数据.
- 审查切换或组合DAT的合理性和有效性.
主要方法:
- 对50项关于DAT的研究进行了系统审查.
- 包括28个关于DBS的研究,12个关于LCIG,10个关于CSAI的研究.
- 包括13项关于切换和组合DAT的研究.
主要成果:
- DATs对PD的运动和非运动症状产生了有利的长期影响.
- 所有的DAT都有特定的不良事件需要考虑.
- 建议在不充分的症状控制或不良事件时切换或组合DAT.
结论:
- 设备辅助疗法对于高级PD的长期管理是安全有效的.
- 建议在初始治疗不足于最佳的情况下切换和组合DAT.
- 未来需要使用先进分析的多中心研究来解决剩余的问题.
更多相关视频
14:56The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
9.0K
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
相关概念视频
Parkinson's Disease: Treatment
215
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
215
Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
